Literature DB >> 6853663

Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia--13-year study.

K Cullen, N S Stenhouse, K L Wearne, T A Welborn.   

Abstract

The mortality of 1564 Busselton subjects has been studied from 1966-79 to determine whether risk factors for cardiovascular disease (CVD) and coronary heart disease (CHD) showed any change in emphasis compared with the Framingham Population Study of 20 yr previously. The Busselton analysis used subjects free of probable and suspect coronary heart disease at onset. In men aged 40-59, systolic blood pressure (SBP), forced expiratory volume (FEV), and serum cholesterol levels were significant independent determining variables for CVD mortality and cholesterol for CHD mortality, with SBP being related to CVD in men aged 60-74 yr. In women, there were few indicators of future vascular risk with no significant determining variable for CVD and CHD in 40-59 yr olds, but blood glucose and FEV were significant risk factors for CVD in women aged 60-74 yr. Cholesterol was unrelated to mortality in women but showed negative relationship with cancer in 60-74 yr old men. In total mortality, smoking in men and women, and obesity in women were significant risk factors; 1 hr serum insulin had a negative relationship in men aged 40-59 yr, and a stronger positive relationship in men aged 60-74 yr, but this may have been due to the close negative association of the variable with body size (i.e. height). More studies are required to ascertain whether glucose and insulin have an aetiological role in vascular disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6853663     DOI: 10.1016/0021-9681(83)90169-8

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  17 in total

1.  Is insulin atherogenic?

Authors:  T J Orchard
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

2.  Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies.

Authors:  J W Yarnell; C C Patterson; D Bainton; P M Sweetnam
Journal:  Heart       Date:  1998-03       Impact factor: 5.994

3.  Decline in lung function and mortality: the Busselton Health Study.

Authors:  G Ryan; M W Knuiman; M L Divitini; A James; A W Musk; H C Bartholomew
Journal:  J Epidemiol Community Health       Date:  1999-04       Impact factor: 3.710

4.  Elevated serum uric acid--a facet of hyperinsulinaemia.

Authors:  M Modan; H Halkin; A Karasik; A Lusky
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

Review 5.  Is insulin atherogenic?

Authors:  R J Jarrett
Journal:  Diabetologia       Date:  1988-02       Impact factor: 10.122

6.  Insulin and cardiovascular disease: biomarker or association?

Authors:  K A M Jandeleit-Dahm; S P Gray
Journal:  Diabetologia       Date:  2012-09-28       Impact factor: 10.122

Review 7.  Periodic health examination, 1993 update: 2. Lowering the blood total cholesterol level to prevent coronary heart disease. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1993-02-15       Impact factor: 8.262

8.  Ischaemic heart disease: association with haematocrit in the British Regional Heart Study.

Authors:  G Wannamethee; A G Shaper; P H Whincup
Journal:  J Epidemiol Community Health       Date:  1994-04       Impact factor: 3.710

9.  Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study.

Authors:  J W Yarnell; P M Sweetnam; V Marks; J D Teale; C H Bolton
Journal:  Br Heart J       Date:  1994-03

10.  Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients.

Authors:  Thomas W Jax; Ansgar J Peters; Gunnar Plehn; Frank-Chris Schoebel
Journal:  Cardiovasc Diabetol       Date:  2009-09-07       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.